(firstQuint)XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer.

 S-1/Cisplatin (SP) is one of the standard treatments of advanced gastric cancer.

 However, evidence of SP on gastric cancer recurrence after adjuvant therapy by the same drug (S-1) is not established.

 The aim of this study is to evaluate the efficacy and safety of Capecitabine/Cisplatin (XP) for gastric cancer patients who relapsed after adjuvant chemotherapy by S-1.

.

 XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer@highlight

The aim of this study is to evaluate efficacy and safety of Capecitabine/Cisplatin for gastric cancer patients who relapsed after adjuvant chemotherapy by S-1.

